CFTR modulator triple
Ivacaftor with tezacaftor and elexacaftor
Brand names: Kaftrio (with Kalydeco)
Adult dose
Dose: 2 tablets (elexacaftor 100mg/tezacaftor 50mg/ivacaftor 75mg) in morning + ivacaftor 150mg in evening; with fat-containing food
Route: PO
Frequency: BD
Clinical pearls
- Cystic fibrosis with at least one F508del mutation; transformative outcome data
- Specialist CF centre prescribing
Contraindications
- Severe hepatic impairment without dose adjustment
Side effects
- Headache
- Diarrhoea
- Rash
- Hepatotoxicity
- Cataract (paediatric)
- Mental health changes (depression, anxiety — rare)
Interactions
- Strong CYP3A4 modulators
- Hormonal contraceptives (interaction reported)
- Warfarin
Monitoring
- LFTs
- Ophthalmic (children)
- Mental health
Reference: BNF; NICE TA787; SmPC; https://bnf.nice.org.uk/drugs/ivacaftor-with-tezacaftor-and-elexacaftor/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024